This potential is illustrated by analogy to the discovery of homozygous mutations for the null allele of C-C chemokine receptor type 5 (CCR-5), which conferred resistance to HIV infection,41 in turn providing a foundation for developing a new class of drugs for treating HIV.42 The gene discussed is CCR5; the disease is HIV infectious disease.